Charles Schwab’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-457,772
Closed -$23.6M 3606
2022
Q3
$23.6M Buy
457,772
+75,528
+20% +$3.9M 0.01% 1258
2022
Q2
$9.47M Buy
382,244
+14,545
+4% +$360K ﹤0.01% 1863
2022
Q1
$9.22M Buy
367,699
+8,653
+2% +$217K ﹤0.01% 2000
2021
Q4
$13.1M Buy
359,046
+32,613
+10% +$1.19M ﹤0.01% 1860
2021
Q3
$5.58M Sell
326,433
-26,705
-8% -$457K ﹤0.01% 2321
2021
Q2
$4.73M Sell
353,138
-21,530
-6% -$288K ﹤0.01% 2381
2021
Q1
$19.2M Buy
374,668
+9,064
+2% +$464K 0.01% 1565
2020
Q4
$22.6M Buy
365,604
+1,650
+0.5% +$102K 0.01% 1309
2020
Q3
$19.9M Buy
363,954
+250,259
+220% +$13.7M 0.01% 1205
2020
Q2
$6.54M Buy
113,695
+10,612
+10% +$611K ﹤0.01% 1897
2020
Q1
$4.14M Buy
103,083
+2,773
+3% +$111K ﹤0.01% 1924
2019
Q4
$3.97M Buy
100,310
+3,616
+4% +$143K ﹤0.01% 2143
2019
Q3
$656K Sell
96,694
-45,868
-32% -$311K ﹤0.01% 2699
2019
Q2
$1.33M Buy
142,562
+93,385
+190% +$869K ﹤0.01% 2486
2019
Q1
$684K Hold
49,177
﹤0.01% 2656
2018
Q4
$537K Hold
49,177
﹤0.01% 2738
2018
Q3
$622K Hold
49,177
﹤0.01% 2767
2018
Q2
$648K Buy
49,177
+6,077
+14% +$80.1K ﹤0.01% 2710
2018
Q1
$587K Buy
43,100
+7,900
+22% +$108K ﹤0.01% 2692
2017
Q4
$210K Hold
35,200
﹤0.01% 2976
2017
Q3
$262K Sell
35,200
-22,600
-39% -$168K ﹤0.01% 2926
2017
Q2
$542K Buy
57,800
+25,800
+81% +$242K ﹤0.01% 2662
2017
Q1
$233K Hold
32,000
﹤0.01% 2905
2016
Q4
$237K Hold
32,000
﹤0.01% 2924
2016
Q3
$194K Hold
32,000
﹤0.01% 2925
2016
Q2
$144K Sell
32,000
-3,000
-9% -$13.5K ﹤0.01% 3014
2016
Q1
$88K Hold
35,000
﹤0.01% 2996
2015
Q4
$284K Hold
35,000
﹤0.01% 2879
2015
Q3
$212K Hold
35,000
﹤0.01% 2942
2015
Q2
$289K Hold
35,000
﹤0.01% 2891
2015
Q1
$265K Hold
35,000
﹤0.01% 2880
2014
Q4
$240K Hold
35,000
﹤0.01% 2927
2014
Q3
$158K Sell
35,000
-16,339
-32% -$73.8K ﹤0.01% 3001
2014
Q2
$301K Sell
51,339
-336
-0.7% -$1.97K ﹤0.01% 2858
2014
Q1
$343K Buy
51,675
+1,260
+2% +$8.36K ﹤0.01% 2747
2013
Q4
$292K Buy
50,415
+1,512
+3% +$8.76K ﹤0.01% 2820
2013
Q3
$268K Buy
48,903
+2,037
+4% +$11.2K ﹤0.01% 2802
2013
Q2
$671K Buy
+46,866
New +$671K ﹤0.01% 2368